Asset Details
Do you wish to reserve the book?
The adaptive life cycle of entrepreneurial ecosystems: the biotechnology cluster
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The adaptive life cycle of entrepreneurial ecosystems: the biotechnology cluster
Do you wish to request the book?
The adaptive life cycle of entrepreneurial ecosystems: the biotechnology cluster
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The adaptive life cycle of entrepreneurial ecosystems: the biotechnology cluster
2017
Overview
We propose an empirical framework for assessing the vibrancy and trajectory of regional entrepreneurial ecosystems. We apply this framework to study the US National Capital Region's localized cluster of biotechnology-related entrepreneurship by building our analysis around a set of indicators of ecosystem vitality proposed by Stangler and Bell-Masterson (2015). This application constitutes an initial attempt at mapping the dynamics of an industry cluster within the adaptive life cycle of a wider regional ecosystem. We find that the biotechnology cluster in the National Capital Region entered a \"reorientation\" stage in the early 2000s, building up stored energy, capital, and connectedness in non-research-oriented activities. An increasing regional presence of large biotech firms in the past 5 years, a highly active and diverse start-up sector, increasing merger and acquisition activity, and declines in regional public funding for medical and clinical trials all suggest a transition of entrepreneurial activity in the region from a dynamic driven by federal research spillovers to one increasingly driven by private sector actors.
Publisher
Springer,Springer US,Springer Nature B.V
